KARLA GERALD: Open Payments
NPI 1518299213 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 76 payments from 21 companies in 2025. Trend: 2023 $1,681 · 2024 $1,327 · 2025 $1,492
Food & beverage: $1,492
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $279 |
| Corcept Therapeutics | 5 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $176 |
| Amgen Inc. | 10 | $150 |
| PFIZER INC. | 6 | $90 |
| ABBVIE INC. | 4 | $79 |
| Averitas Pharma Inc. | 3 | $69 |
| Lilly USA, LLC | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Novo Nordisk Inc | 3 | $56 |
Products named: Korlym, Kerendia, AIRSUPRA, BREZTRI, ELIQUIS, EVENITY, QUTENZA, MOUNJARO.
Industry payments across MS — which companies pay providers there.
